[On the endocrine substrate of diffuse female (androgenetic) alopecia].
D000328:Adult; D000368:Aged; D000505:Alopecia / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism*; D000728:Androgens / Q000009:adverse effects / Q000378:metabolism*; D004958:Estradiol / Q000652:urine; D004964:Estriol / Q000652:urine; D004970:Estrone / Q000652:urine; D005260:Female; D006062:Gonadotropins / Q000652:urine; D006801:Humans; D008234:Lynestrenol / Q000627:therapeutic use; D008297:Male; D008593:Menopause; D011276:Pregnanediol / Q000652:urine; D013739:Testosterone / Q000096:biosynthesis / Q000652:urine
D000728:Androgens; D006062:Gonadotropins; D004970:Estrone; D013739:Testosterone; D004958:Estradiol; D004964:Estriol; D011276:Pregnanediol; D008234:Lynestrenol
Uber das endokrine Substrat der diffusen weiblichen (andro-genetischen) Alopecie.